COVID-19 Impact on Global OTC Anti-Infective Products Market Insights, Forecast to 2026

COVID-19 Impact on Global OTC Anti-Infective Products Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 OTC Anti-Infective Products Product Introduction
1.2 Market Segments
1.3 Key OTC Anti-Infective Products Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type
1.4.2 Antifungals
1.4.3 Antiseptic
1.4.4 Antiparasitics
1.5 Market by Application
1.5.1 Global OTC Anti-Infective Products Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Stores
1.5.5 E-Commerce
1.6 Coronavirus Disease 2019 (Covid-19): OTC Anti-Infective Products Industry Impact
1.6.1 How the Covid-19 is Affecting the OTC Anti-Infective Products Industry
1.6.1.1 OTC Anti-Infective Products Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and OTC Anti-Infective Products Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for OTC Anti-Infective Products Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global OTC Anti-Infective Products Market Size Estimates and Forecasts
2.1.1 Global OTC Anti-Infective Products Revenue 2015-2026
2.1.2 Global OTC Anti-Infective Products Sales 2015-2026
2.2 OTC Anti-Infective Products Market Size by Region: 2020 Versus 2026
2.2.1 Global OTC Anti-Infective Products Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global OTC Anti-Infective Products Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global OTC Anti-Infective Products Competitor Landscape by Players
3.1 OTC Anti-Infective Products Sales by Manufacturers
3.1.1 OTC Anti-Infective Products Sales by Manufacturers (2015-2020)
3.1.2 OTC Anti-Infective Products Sales Market Share by Manufacturers (2015-2020)
3.2 OTC Anti-Infective Products Revenue by Manufacturers
3.2.1 OTC Anti-Infective Products Revenue by Manufacturers (2015-2020)
3.2.2 OTC Anti-Infective Products Revenue Share by Manufacturers (2015-2020)
3.2.3 Global OTC Anti-Infective Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Revenue in 2019
3.2.5 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 OTC Anti-Infective Products Price by Manufacturers
3.4 OTC Anti-Infective Products Manufacturing Base Distribution, Product Types
3.4.1 OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers OTC Anti-Infective Products Product Type
3.4.3 Date of International Manufacturers Enter into OTC Anti-Infective Products Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global OTC Anti-Infective Products Market Size by Type (2015-2020)
4.1.1 Global OTC Anti-Infective Products Sales by Type (2015-2020)
4.1.2 Global OTC Anti-Infective Products Revenue by Type (2015-2020)
4.1.3 OTC Anti-Infective Products Average Selling Price (ASP) by Type (2015-2026)
4.2 Global OTC Anti-Infective Products Market Size Forecast by Type (2021-2026)
4.2.1 Global OTC Anti-Infective Products Sales Forecast by Type (2021-2026)
4.2.2 Global OTC Anti-Infective Products Revenue Forecast by Type (2021-2026)
4.2.3 OTC Anti-Infective Products Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global OTC Anti-Infective Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global OTC Anti-Infective Products Market Size by Application (2015-2020)
5.1.1 Global OTC Anti-Infective Products Sales by Application (2015-2020)
5.1.2 Global OTC Anti-Infective Products Revenue by Application (2015-2020)
5.1.3 OTC Anti-Infective Products Price by Application (2015-2020)
5.2 OTC Anti-Infective Products Market Size Forecast by Application (2021-2026)
5.2.1 Global OTC Anti-Infective Products Sales Forecast by Application (2021-2026)
5.2.2 Global OTC Anti-Infective Products Revenue Forecast by Application (2021-2026)
5.2.3 Global OTC Anti-Infective Products Price Forecast by Application (2021-2026)
6 North America
6.1 North America OTC Anti-Infective Products by Country
6.1.1 North America OTC Anti-Infective Products Sales by Country
6.1.2 North America OTC Anti-Infective Products Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America OTC Anti-Infective Products Market Facts & Figures by Type
6.3 North America OTC Anti-Infective Products Market Facts & Figures by Application
7 Europe
7.1 Europe OTC Anti-Infective Products by Country
7.1.1 Europe OTC Anti-Infective Products Sales by Country
7.1.2 Europe OTC Anti-Infective Products Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe OTC Anti-Infective Products Market Facts & Figures by Type
7.3 Europe OTC Anti-Infective Products Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific OTC Anti-Infective Products by Region
8.1.1 Asia Pacific OTC Anti-Infective Products Sales by Region
8.1.2 Asia Pacific OTC Anti-Infective Products Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Type
8.3 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Application
9 Latin America
9.1 Latin America OTC Anti-Infective Products by Country
9.1.1 Latin America OTC Anti-Infective Products Sales by Country
9.1.2 Latin America OTC Anti-Infective Products Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America OTC Anti-Infective Products Market Facts & Figures by Type
9.3 Central & South America OTC Anti-Infective Products Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa OTC Anti-Infective Products by Country
10.1.1 Middle East and Africa OTC Anti-Infective Products Sales by Country
10.1.2 Middle East and Africa OTC Anti-Infective Products Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Type
10.3 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description, Business Overview and Total Revenue
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck OTC Anti-Infective Products Products Offered
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer OTC Anti-Infective Products Products Offered
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description, Business Overview and Total Revenue
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis OTC Anti-Infective Products Products Offered
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Description, Business Overview and Total Revenue
11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbott OTC Anti-Infective Products Products Offered
11.5.5 Abbott Recent Development
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description, Business Overview and Total Revenue
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi OTC Anti-Infective Products Products Offered
11.6.5 Sanofi Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb OTC Anti-Infective Products Products Offered
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Description, Business Overview and Total Revenue
11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Roche OTC Anti-Infective Products Products Offered
11.8.5 Roche Recent Development
11.9 NanoViricides
11.9.1 NanoViricides Corporation Information
11.9.2 NanoViricides Description, Business Overview and Total Revenue
11.9.3 NanoViricides Sales, Revenue and Gross Margin (2015-2020)
11.9.4 NanoViricides OTC Anti-Infective Products Products Offered
11.9.5 NanoViricides Recent Development
11.10 Novabay Pharmaceuticals
11.10.1 Novabay Pharmaceuticals Corporation Information
11.10.2 Novabay Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Novabay Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novabay Pharmaceuticals OTC Anti-Infective Products Products Offered
11.10.5 Novabay Pharmaceuticals Recent Development
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.12 Basilea Pharmaceutica
11.12.1 Basilea Pharmaceutica Corporation Information
11.12.2 Basilea Pharmaceutica Description, Business Overview and Total Revenue
11.12.3 Basilea Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Basilea Pharmaceutica Products Offered
11.12.5 Basilea Pharmaceutica Recent Development
11.13 MerLion Pharma
11.13.1 MerLion Pharma Corporation Information
11.13.2 MerLion Pharma Description, Business Overview and Total Revenue
11.13.3 MerLion Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 MerLion Pharma Products Offered
11.13.5 MerLion Pharma Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 OTC Anti-Infective Products Market Estimates and Projections by Region
12.1.1 Global OTC Anti-Infective Products Sales Forecast by Regions 2021-2026
12.1.2 Global OTC Anti-Infective Products Revenue Forecast by Regions 2021-2026
12.2 North America OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.2.1 North America: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.2.2 North America: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.2.3 North America: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
12.3 Europe OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.3.1 Europe: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.3.2 Europe: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.3.3 Europe: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.4.2 Asia Pacific: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: OTC Anti-Infective Products Market Size Forecast by Region (2021-2026)
12.5 Latin America OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.5.1 Latin America: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.5.2 Latin America: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.5.3 Latin America: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key OTC Anti-Infective Products Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 OTC Anti-Infective Products Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details

List of Tables
Table 1. OTC Anti-Infective Products Market Segments
Table 2. Ranking of Global Top OTC Anti-Infective Products Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global OTC Anti-Infective Products Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Antifungals
Table 5. Major Manufacturers of Antiseptic
Table 6. Major Manufacturers of Antiparasitics
Table 7. COVID-19 Impact Global Market: (Four OTC Anti-Infective Products Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for OTC Anti-Infective Products Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for OTC Anti-Infective Products Players to Combat Covid-19 Impact
Table 12. Global OTC Anti-Infective Products Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global OTC Anti-Infective Products Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global OTC Anti-Infective Products Sales by Regions 2015-2020 (K Units)
Table 15. Global OTC Anti-Infective Products Sales Market Share by Regions (2015-2020)
Table 16. Global OTC Anti-Infective Products Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global OTC Anti-Infective Products Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global OTC Anti-Infective Products Sales Share by Manufacturers (2015-2020)
Table 19. Global OTC Anti-Infective Products Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Anti-Infective Products as of 2019)
Table 21. OTC Anti-Infective Products Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. OTC Anti-Infective Products Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers OTC Anti-Infective Products Price (2015-2020) (USD/Unit)
Table 24. OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers OTC Anti-Infective Products Product Type
Table 26. Date of International Manufacturers Enter into OTC Anti-Infective Products Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 29. Global OTC Anti-Infective Products Sales Share by Type (2015-2020)
Table 30. Global OTC Anti-Infective Products Revenue by Type (2015-2020) (US$ Million)
Table 31. Global OTC Anti-Infective Products Revenue Share by Type (2015-2020)
Table 32. OTC Anti-Infective Products Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 34. Global OTC Anti-Infective Products Sales Share by Application (2015-2020)
Table 35. North America OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 36. North America OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 37. North America OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 38. North America OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 39. North America OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 40. North America OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 41. North America OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 42. North America OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 43. Europe OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 44. Europe OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 45. Europe OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 47. Europe OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 48. Europe OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 49. Europe OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 50. Europe OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific OTC Anti-Infective Products Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific OTC Anti-Infective Products Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 59. Latin America OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 60. Latin America OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 63. Latin America OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 64. Latin America OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 65. Latin America OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 66. Latin America OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Major Businesses
Table 77. GlaxoSmithKline OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Major Businesses
Table 82. Merck OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck Product
Table 84. Merck Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Major Businesses
Table 87. Pfizer OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer Product
Table 89. Pfizer Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Major Businesses
Table 92. Novartis OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Product
Table 94. Novartis Recent Development
Table 95. Abbott Corporation Information
Table 96. Abbott Description and Major Businesses
Table 97. Abbott OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Abbott Product
Table 99. Abbott Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Major Businesses
Table 102. Sanofi OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sanofi Product
Table 104. Sanofi Recent Development
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Major Businesses
Table 107. Bristol-Myers Squibb OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Bristol-Myers Squibb Product
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Roche Corporation Information
Table 111. Roche Description and Major Businesses
Table 112. Roche OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Roche Product
Table 114. Roche Recent Development
Table 115. NanoViricides Corporation Information
Table 116. NanoViricides Description and Major Businesses
Table 117. NanoViricides OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. NanoViricides Product
Table 119. NanoViricides Recent Development
Table 120. Novabay Pharmaceuticals Corporation Information
Table 121. Novabay Pharmaceuticals Description and Major Businesses
Table 122. Novabay Pharmaceuticals OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Novabay Pharmaceuticals Product
Table 124. Novabay Pharmaceuticals Recent Development
Table 125. Optimer Pharmaceuticals Corporation Information
Table 126. Optimer Pharmaceuticals Description and Major Businesses
Table 127. Optimer Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Optimer Pharmaceuticals Product
Table 129. Optimer Pharmaceuticals Recent Development
Table 130. Basilea Pharmaceutica Corporation Information
Table 131. Basilea Pharmaceutica Description and Major Businesses
Table 132. Basilea Pharmaceutica OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Basilea Pharmaceutica Product
Table 134. Basilea Pharmaceutica Recent Development
Table 135. MerLion Pharma Corporation Information
Table 136. MerLion Pharma Description and Major Businesses
Table 137. MerLion Pharma OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. MerLion Pharma Product
Table 139. MerLion Pharma Recent Development
Table 140. Global OTC Anti-Infective Products Sales Forecast by Regions (2021-2026) (K Units)
Table 141. Global OTC Anti-Infective Products Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global OTC Anti-Infective Products Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global OTC Anti-Infective Products Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 145. North America: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 147. Europe: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: OTC Anti-Infective Products Sales Forecast by Region (2021-2026) (K Units)
Table 149. Asia Pacific: OTC Anti-Infective Products Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 151. Latin America: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 153. Middle East and Africa: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key OTC Anti-Infective Products Players
Table 158. OTC Anti-Infective Products Customers List
Table 159. OTC Anti-Infective Products Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources

List of Figures
Figure 1. OTC Anti-Infective Products Product Picture
Figure 2. Global OTC Anti-Infective Products Sales Market Share by Type in 2020 & 2026
Figure 3. Antifungals Product Picture
Figure 4. Antiseptic Product Picture
Figure 5. Antiparasitics Product Picture
Figure 6. Global OTC Anti-Infective Products Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Drug Stores
Figure 9. Retail Stores
Figure 10. E-Commerce
Figure 11. OTC Anti-Infective Products Report Years Considered
Figure 12. Global OTC Anti-Infective Products Market Size 2015-2026 (US$ Million)
Figure 13. Global OTC Anti-Infective Products Sales 2015-2026 (K Units)
Figure 14. Global OTC Anti-Infective Products Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global OTC Anti-Infective Products Sales Market Share by Region (2015-2020)
Figure 16. Global OTC Anti-Infective Products Sales Market Share by Region in 2019
Figure 17. Global OTC Anti-Infective Products Revenue Market Share by Region (2015-2020)
Figure 18. Global OTC Anti-Infective Products Revenue Market Share by Region in 2019
Figure 19. Global OTC Anti-Infective Products Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by OTC Anti-Infective Products Revenue in 2019
Figure 21. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Figure 23. Global OTC Anti-Infective Products Sales Market Share by Type in 2019
Figure 24. Global OTC Anti-Infective Products Revenue Market Share by Type (2015-2020)
Figure 25. Global OTC Anti-Infective Products Revenue Market Share by Type in 2019
Figure 26. Global OTC Anti-Infective Products Market Share by Price Range (2015-2020)
Figure 27. Global OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Figure 28. Global OTC Anti-Infective Products Sales Market Share by Application in 2019
Figure 29. Global OTC Anti-Infective Products Revenue Market Share by Application (2015-2020)
Figure 30. Global OTC Anti-Infective Products Revenue Market Share by Application in 2019
Figure 31. North America OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America OTC Anti-Infective Products Sales Market Share by Country in 2019
Figure 34. North America OTC Anti-Infective Products Revenue Market Share by Country in 2019
Figure 35. U.S. OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America OTC Anti-Infective Products Market Share by Type in 2019
Figure 40. North America OTC Anti-Infective Products Market Share by Application in 2019
Figure 41. Europe OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe OTC Anti-Infective Products Sales Market Share by Country in 2019
Figure 44. Europe OTC Anti-Infective Products Revenue Market Share by Country in 2019
Figure 45. Germany OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 48. France OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe OTC Anti-Infective Products Market Share by Type in 2019
Figure 56. Europe OTC Anti-Infective Products Market Share by Application in 2019
Figure 57. Asia Pacific OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region in 2019
Figure 60. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region in 2019
Figure 61. China OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 62. China OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 68. India OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Mi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs